Investment Thesis
CVS demonstrates concerning fundamental deterioration with revenue growth of 7.8% failing to translate into earnings expansion (net income flat YoY) and EPS declining sharply 62%, indicating severe margin compression and/or shareholder dilution. Weak liquidity metrics (current ratio 0.87x, quick ratio 0.66x) combined with poor capital efficiency (ROE 3.8%, ROA 1.2%) and high debt burden ($60.5B) relative to profitability suggest the business is struggling to create shareholder value despite scale.
Strengths
- Positive revenue growth of 7.8% YoY demonstrates continued market demand
- Positive free cash flow generation of $3.4B provides debt servicing capacity
- Adequate interest coverage ratio of 6.5x indicates debt is manageable at current levels
Risks
- Severe margin compression: 7.8% revenue growth producing 0.0% net income growth signals deteriorating profitability
- Alarming liquidity position with current ratio 0.87x and quick ratio 0.66x indicating potential short-term payment challenges
- Historically poor capital returns (ROE 3.8%, ROA 1.2%) and 62% EPS decline suggest structural business challenges and significant shareholder dilution
- High leverage with $60.5B long-term debt limits financial flexibility despite manageable 0.78x debt-to-equity ratio
Key Metrics to Watch
- Net profit margin trend - must expand or show stabilization to justify hold
- Operating cash flow sustainability - declining trend would signal business deterioration
- Current and quick ratios - must improve above 1.0x and 0.8x respectively for financial health
- EPS trajectory - must stabilize and turn positive YoY to demonstrate improving shareholder value
Financial Metrics
Revenue
100.4B
Net Income
2.9B
EPS (Diluted)
$2.30
Free Cash Flow
3.4B
Total Assets
253.0B
Cash
9.5B
Profitability Ratios
Gross Margin
21.3%
Operating Margin
4.7%
Net Margin
2.9%
ROE
3.8%
ROA
1.2%
FCF Margin
3.4%
Balance Sheet & Liquidity
Current Ratio
0.87x
Quick Ratio
0.66x
Debt/Equity
0.78x
Debt/Assets
69.3%
Interest Coverage
6.54x
Long-term Debt
60.5B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-08T09:49:54.643382 |
Data as of: 2026-03-31 |
Powered by Claude AI